Paper33859820
Effects of obesity and 10 weeks metformin treatment on liver steatosis.
Hakkak R and 4 others. Biomed Rep, 2021. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. Effects of obesity and 10 weeks metformin treatment on liver steatosis. Papers, record 33859820. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33859820
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| P20 GM109096 | NIGMS NIH HHS | United States | P20GM109096 | PubMed |
Source NIH RePORTER
References33
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 18492523 | Addition of metformin to a lifestyle modification program in adolescents with insulin resistance. | J Pediatr | 2008 | https://conductscience.org/library/papers/18492523 | PubMed |
| 2 | 32155673 | A novel metformin derivative showed improvement of lipid metabolism in obese rats with type 2 diabetes. | Clin Exp Pharmacol Physiol | 2020 | https://conductscience.org/library/papers/32155673 | PubMed |
| 3 | 18556965 | Use of metformin in obese adolescents with hyperinsulinemia: a 6-month, randomized, double-blind, placebo-controlled clinical trial. | J Pediatr Endocrinol Metab | 2008 | https://conductscience.org/library/papers/18556965 | PubMed |
| 4 | 20124139 | Metformin extended release treatment of adolescent obesity: a 48-week randomized, double-blind, placebo-controlled trial with 48-week follow-up. | Arch Pediatr Adolesc Med | 2010 | https://conductscience.org/library/papers/20124139 | PubMed |
| 5 | 28052534 | Metformin; a review of its history and future: from lilac to longevity. | Pediatr Diabetes | 2017 | https://conductscience.org/library/papers/28052534 | PubMed |
| 6 | 17402991 | GI epidemiology: nonalcoholic fatty liver disease. | Aliment Pharmacol Ther | 2007 | https://conductscience.org/library/papers/17402991 | PubMed |
| 7 | 31749893 | Long-term treatment with metformin in the prevention of fatty liver in Zucker diabetic fatty rats. | Diabetol Metab Syndr | 2019 | https://conductscience.org/library/papers/31749893 | PubMed |
| 8 | 10048159 | Diet and risk of ethanol-induced hepatotoxicity: carbohydrate-fat relationships in rats. | Toxicol Sci | 1999 | https://conductscience.org/library/papers/10048159 | PubMed |
| 9 | 10973319 | Metformin reverses fatty liver disease in obese, leptin-deficient mice. | Nat Med | 2000 | https://conductscience.org/library/papers/10973319 | PubMed |
| 10 | 30038219 | Metformin inhibits gluconeogenesis via a redox-dependent mechanism in vivo. | Nat Med | 2018 | https://conductscience.org/library/papers/30038219 | PubMed |
| 11 | 11567710 | Metformin in non-alcoholic steatohepatitis. | Lancet | 2001 | https://conductscience.org/library/papers/11567710 | PubMed |
| 12 | 5016304 | Fat mobilization in vitro and in vivo in the genetically obese Zucker rat "fatty". | J Lipid Res | 1972 | https://conductscience.org/library/papers/5016304 | PubMed |
| 13 | 15277403 | Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes. | Diabetes | 2004 | https://conductscience.org/library/papers/15277403 | PubMed |
| 14 | 23084707 | Increasing prevalence of nonalcoholic fatty liver disease among United States adolescents, 1988-1994 to 2007-2010. | J Pediatr | 2013 | https://conductscience.org/library/papers/23084707 | PubMed |
| 15 | 25210757 | Metformin treatment improves weight and dyslipidemia in children with metabolic syndrome. | J Pediatr Endocrinol Metab | 2015 | https://conductscience.org/library/papers/25210757 | PubMed |
| 16 | 22528625 | Dietary soy protein induces hepatic lipogenic enzyme gene expression while suppressing hepatosteatosis in obese female Zucker rats bearing DMBA-initiated mammary tumors. | Genes Nutr | 2012 | https://conductscience.org/library/papers/22528625 | PubMed |
| 17 | 29757972 | Short-Term Soy Protein Isolate Feeding Prevents Liver Steatosis and Reduces Serum ALT and AST Levels in Obese Female Zucker Rats. | Biomedicines | 2018 | https://conductscience.org/library/papers/29757972 | PubMed |
| 18 | 25676019 | Metformin and metabolic diseases: a focus on hepatic aspects. | Front Med | 2015 | https://conductscience.org/library/papers/25676019 | PubMed |
| 19 | 20071470 | Prevalence of high body mass index in US children and adolescents, 2007-2008. | JAMA | 2010 | https://conductscience.org/library/papers/20071470 | PubMed |
| 20 | 26186426 | Short- and Long-Term Soy Diet Versus Casein Protects Liver Steatosis Independent of the Arginine Content. | J Med Food | 2015 | https://conductscience.org/library/papers/26186426 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42451064 | Impaired Renal Mitochondria and Bioenergetics During Obesity-Associated NAFLD. | Nutrients | 2026 | https://conductscience.org/library/papers/42451064 | PubMed |
| 40647220 | Obesity-Associated NAFLD Coexists with a Chronic Inflammatory Kidney Condition That Is Partially Mitigated by Short-Term Oral Metformin. | Nutrients | 2025 | https://conductscience.org/library/papers/40647220 | PubMed |
| 37627299 | Effect of Metformin Treatment on Serum Metabolic Profile Changes in Lean and Obese Zucker Rat Model for Fatty Liver Disease. | Biomolecules | 2023 | https://conductscience.org/library/papers/37627299 | PubMed |
| 37271372 | Hepatic insulin receptor: new views on the mechanisms of liver disease. | Metabolism | 2023 | https://conductscience.org/library/papers/37271372 | PubMed |
| 35432282 | Short-Term Metformin Treatment Enriches Bacteroides dorei in an Obese Liver Steatosis Zucker Rat Model. | Front Microbiol | 2022 | https://conductscience.org/library/papers/35432282 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| INS | 3630 | PubTator's text mining | https://conductscience.org/library/genes/3630 | NCBI Gene |
| LEP | 3952 | PubTator's text mining | https://conductscience.org/library/genes/3952 | NCBI Gene |
| PTGS2 | 5743 | PubTator's text mining | https://conductscience.org/library/genes/5743 | NCBI Gene |
| SLC17A5 | 26503 | PubTator's text mining | https://conductscience.org/library/genes/26503 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33859820
GET https://conductscience.org/api/papers/v1/33859820/references?page=2